L Desjardins Selected Research

L Desjardins Research Topics

16	Neoplasms (Cancer) 05/2018 - 06/2000
10	Melanoma (Melanoma, Malignant) 02/2017 - 02/2000
10	Retinoblastoma (Glioblastoma, Retinal) 01/2016 - 02/2000
10	Uveal melanoma 12/2010 - 02/2000
3	Neoplasm Metastasis (Metastasis) 06/2015 - 10/2005
3	Hemorrhage 05/2009 - 05/2004
2	Macular Degeneration (Age-Related Maculopathy) 05/2013 - 11/2009
2	Genetic Predisposition to Disease (Genetic Predisposition) 12/2010 - 06/2001
2	Necrosis 12/2007 - 11/2001
2	Neovascular Glaucoma 10/2005 - 01/2001
1	Lymphoma (Lymphomas) 05/2013
1	Intraocular Lymphoma 05/2013
1	Uveitis 05/2013
1	Endophthalmitis (Ophthalmia) 05/2013
1	Vascular Calcification 07/2012
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2010
1	Breast Neoplasms (Breast Cancer) 07/2010
1	Hematoma 11/2009
1	Rhabdomyosarcoma 05/2009
1	Hemangioma (Angioma) 05/2009
1	Adenocarcinoma 12/2007
1	Phototoxic Dermatitis (Phototoxicity) 12/2007
1	Monosomy 09/2006
1	Cicatrix (Scar) 01/2006
1	Glaucoma 01/2006
1	Embolism (Embolus) 09/2004
1	Thromboembolism 09/2004
1	Venous Thromboembolism 05/2004
1	Hyperthermia 02/2003
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2003
1	Genomic Instability 12/2001
1	Anterior Uveitis 11/2001
1	Inflammation (Inflammations) 11/2001
1	Osteosarcoma (Osteogenic Sarcoma) 06/2001
1	Optic Nerve Diseases (Optic Neuropathy) 06/2000
1	Cutaneous Malignant Melanoma 02/2000

8	Protons (Proton)IBA 07/2010 - 06/2000
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 12/2010 - 02/2000
2	AnticoagulantsIBA 11/2009 - 05/2004
2	Dihydrotachysterol (AT 10)IBA 10/2005 - 02/2004
2	Warfarin (Coumadin)FDA LinkGeneric 09/2004 - 05/2004
2	Carboplatin (JM8)FDA LinkGeneric 03/2003 - 02/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2013
1	Vascular Endothelial Growth FactorsIBA 05/2013
1	Ranibizumab (Lucentis)FDA Link 05/2013
1	Biomarkers (Surrogate Marker)IBA 07/2012
1	Hormones (Hormone)IBA 07/2012
1	MineralsIBA 07/2012
1	Fibroblast Growth Factor-23IBA 07/2012
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2010
1	fibrin fragment D (D-dimer)IBA 10/2010
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2009
1	Phosphotransferases (Kinase)IBA 07/2009
1	PorphyrinsIBA 12/2007
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2007
1	temoporfinIBA 12/2007
1	Photosensitizing Agents (Photosensitizers)IBA 12/2007
1	CobaltIBA 10/2005
1	Retinaldehyde (Retinal)IBA 09/2005
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2004
1	Etoposide (VP 16)FDA LinkGeneric 03/2003
1	IodineIBA 03/2003
1	Mydriatics (Cycloplegics)IBA 11/2001
1	CytokinesIBA 11/2001
1	SteroidsIBA 11/2001
1	Cyclin-Dependent Kinase 4IBA 02/2000

7	Radiotherapy 02/2017 - 11/2000
7	Proton Therapy 02/2017 - 04/2000
6	Therapeutics 06/2015 - 06/2000
5	Conservative Treatment 01/2016 - 06/2000
5	Drug Therapy (Chemotherapy) 01/2016 - 02/2003
2	Neoadjuvant Therapy 01/2016 - 03/2003
2	Induced Hyperthermia (Thermotherapy) 01/2006 - 02/2003
2	Aftercare (After-Treatment) 05/2004 - 11/2001
1	Myocutaneous Flap 05/2018
1	Laparotomy 06/2015
1	Injections 05/2013
1	Intravitreal Injections 05/2013
1	Decompression 05/2009
1	Brachytherapy 09/2004
1	Duration of Therapy 05/2004
1	Semiconductor Lasers 02/2003
1	Lasers (Laser) 02/2003